Philip A Patten

Title: **The Innovative Journey of Philip A. Patten**

Introduction

Philip A. Patten, based in Portola Valley, California, is a notable inventor recognized for his contributions to antibody technology. With a keen focus on enhancing the specificity and functionality of antibodies, his work has implications in various fields, including therapeutic applications and biological detection.

Latest Patents

Philip A. Patten holds a patent related to "Antibody diversity generation." This innovative patent provides methods for improving antibodies through diverse DNA diversification and selection procedures. Key enhancements detailed in the patent include increased affinity, altered specificity, improved effector function, and reduced antigenicity, such as humanization. The patent also presents libraries of recombinant antibody sequences and introduces novel phage display vectors. Furthermore, it offers methods for the coevolution of antibodies with their cognate antigens, particularly in evolving HIV envelope proteins that exhibit enhanced antigenicity and broadly neutralizing properties. Additionally, it encompasses methods for improving antibodies aimed at detecting biological warfare agents.

Career Highlights

Philip A. Patten is affiliated with Maxygen, Inc., where he leverages his expertise to advance biotechnological innovations. His research has not only contributed to scientific understanding but also provided practical applications in medicine and public safety.

Collaborations

Throughout his career, Philip A. Patten has collaborated with talented individuals such as Erik E. Karrer and Steven Henry Bass. These collaborations have played a significant role in enhancing his research and broadening the impact of their collective work within the biotechnology sector.

Conclusion

Philip A. Patten's innovative contributions to antibody technology exemplify how inventive minds can drive advancements in scientific research and public health. His patent serves as a testament to the potential applications of biotechnology in areas that require enhanced detection and therapeutic strategies, paving the way for future discoveries in the field.